You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug interaction, artemether-lumefantrine, atazanavir-ritonavir, LUTH

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

Not yet recruiting
  • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
  • +6 more
    • (no location specified)
    Aug 9, 2022

    Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • (no location specified)
    Feb 23, 2021

    Efficacy for Cholib in Korean Patients Under "New Drug

    Completed
    • Dyslipidemias
      • Bucheon, Korea, Republic of
      • +9 more
      Nov 10, 2020

      Tuberculosis, Pulmonary Trial in Kaohsiung, Taipei, Taoyuan City (4-month rifapentine-based regimen)

      Not yet recruiting
      • Tuberculosis, Pulmonary
      • 4-month rifapentine-based regimen
      • Kaohsiung, Taiwan
      • +3 more
      Apr 22, 2021

      Recurrent Endometrial Cancer Trial in France (Olaparib, metformin, metronomic cyclophosphamide)

      Completed
      • Recurrent Endometrial Cancer
      • Caen, France
      • +5 more
      Dec 6, 2021

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (REGN3918)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Sha Tin, Hong Kong
      • +11 more
      Jul 13, 2021

      Communication, Palliative Sedation Trial in Yangsan (healthcare provider's recommended communication with sympathy and printed

      Recruiting
      • Communication, Palliative Sedation
      • healthcare provider's recommended communication with sympathy and printed paper
      • Yangsan, Korea, Republic of
        Pusan National University Yangsan Hospital
      Oct 31, 2021

      Detection of LADA in a Hospital in the Mexican Southeast

      Completed
      • Latent Autoimmune Diabetes
        • Villahermosa, Tabasco, Mexico
          Isela Esther Juarez Rojop
        Feb 10, 2022

        Normal Physiology, Healthy Trial run by the NIAID (Amoxicillin, Azithromycin, Control)

        Recruiting
        • Normal Physiology
        • Healthy
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        MDS Trial in United States (ARRY-614, p38/Tie2 inhibitor; oral)

        Completed
        • Myelodysplastic Syndromes
        • ARRY-614, p38/Tie2 inhibitor; oral
        • Tampa, Florida
        • +3 more
        Sep 4, 2020

        Trigeminal Neuralgia Trial in Rohtak (Oxcarbazepine, Carbamazepine)

        Recruiting
        • Trigeminal Neuralgia
        • Rohtak, Haryana, India
        • +1 more
        Oct 14, 2021

        Opioid Use, Opioids; Harmful Use, Hyperalgesia Trial in Winnipeg (Patient Education Workshop (PEWs), Multidisciplinary Tapering

        Recruiting
        • Opioid Use
        • +3 more
        • Patient Education Workshop (PEWs)
        • Multidisciplinary Tapering Program
        • Winnipeg, Manitoba, Canada
        • +3 more
        May 13, 2022

        Hepatocellular Carcinoma, Liver Cirrhosis Trial in New Delhi (Lenvatinib, Mebendazole, Placebo)

        Recruiting
        • Hepatocellular Carcinoma
        • Liver Cirrhosis
        • New Delhi, Delhi, India
          Institute of Liver & Biliary Sciences
        Oct 4, 2021

        Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral)

        Completed
        • Advanced Cancer
        • ARRY-334543, EGFR/ErbB2 inhibitor; oral
        • Philadelphia, Pennsylvania
        • +4 more
        Oct 12, 2020

        Diabetes, Type 2 Trial in Hachioji, Sumida-ku, Fukuoka (LY3209590, Placebo)

        Completed
        • Diabetes Mellitus, Type 2
        • Hachioji, Tokyo, Japan
        • +2 more
        Nov 13, 2020

        Peripheral Arterial Disease Trial in Belgium, Italy, Spain (Luminor-14 Paclitaxel eluting balloon)

        Active, not recruiting
        • Peripheral Arterial Disease
        • Luminor-14 Paclitaxel eluting balloon
        • Aalst, Oost-Vlaanderen, Belgium
        • +6 more
        Feb 8, 2022

        Pancreatic Cancer Trial in Houston (multiTAA specific T cells)

        Active, not recruiting
        • Pancreatic Cancer
        • multiTAA specific T cells
        • Houston, Texas
        • +2 more
        Feb 7, 2022

        Great Saphenous Vein Incompetence, Visible Varicosities Trial in United States (endovenous ablation+polidocanol injectable

        Completed
        Has Results
        • Great Saphenous Vein Incompetence
        • Visible Varicosities
        • endovenous ablation+polidocanol injectable microfoam 0.125%
        • +2 more
        • Scottsdale, Arizona
        • +6 more
        Apr 19, 2021

        Histamine Biotransformation Trial in Kansas City (validated techniques for histamine response, new technique for histamine

        Withdrawn
        • Histamine Biotransformation
        • validated techniques for histamine response
        • new technique for histamine response
        • Kansas City, Missouri
          Children's Mercy Hospitals and Clinics
        Jan 5, 2021

        Field Actinic Keratoses, Basal Cell Carcinoma, Bowen's Disease Trial (Metvix (methyl aminolevulinate))

        No longer available
        • Field Actinic Keratoses
        • +2 more
        • Metvix (methyl aminolevulinate)
        • (no location specified)
        Feb 16, 2021

        Dopamine, Bronchodilation, Heart Trial in Szeged (Dopamine administration)

        Unknown status
        • Dopamine
        • +4 more
        • Dopamine administration
        • Szeged, Hungary
          Barna Babik
        Feb 10, 2021

        Dysphagia, Dysphonia Trial (Intravenous Ketorolac, Intravenous Dexamethasone, Placebo)

        Not yet recruiting
        • Dysphagia
        • Dysphonia
        • Intravenous Ketorolac
        • +2 more
        • (no location specified)
        Dec 2, 2020

        Dementia With Lewy Bodies Trial in Washington (Placebo, 192 mg powder of K0706, 384 mg powder of K0706)

        Recruiting
        • Dementia With Lewy Bodies
        • Placebo
        • +2 more
        • Washington, District of Columbia
          MedStar Georgetown University Hospital
        Aug 16, 2021

        Type 1 Hyperlipoproteinemia Trial in Dallas (SLx-4090 , Orlistat Placebo, Orlistat)

        Terminated
        Has Results
        • Type 1 Hyperlipoproteinemia
        • SLx-4090 placebo
        • +3 more
        • Dallas, Texas
        • +1 more
        Jul 26, 2021

        Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)

        Recruiting
        • Gastrointestinal Stromal Tumors
        • +3 more
        • La Jolla, California
        • +4 more
        Aug 17, 2021